Company / R&D per Share
ADC Therapeutics SA R&D per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.05
FY2025
5-year range
$1.05 / $2.31
FY2023-FY2025
Trend
-31.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $2.31 to $1.05 over the past 2 years.
Based on SEC 10-K filings.
1.05 in FY2025.
Declined from $2.31 to $1.05 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 31.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.05 | -31.9% |
| FY2024 | $1.54 | -33.2% |
| FY2023 | $2.31 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026